Table 1. Outcomes of Relapsed Patients in Studies Utilizing Conventional Dose Chemotherapy.

Ca: carboplatin; Ci: cisplatin; Cy: cyclophosphamide; D: docetaxel; E: etoposide; G: gemcitabine; I: ifosfamide; Ir: irinotecan; m: months; Te: temozolomide; To: topotecan; V: vincristine; NL: Not listed

Study	Agents used	Number of patients	Response rate	Overall survival	Event free survival
Navid et al. [6]	G + D	22	29%	NL	NL
Van Winkle et al. [7]	I + Ca + E	97	51%	1 yr: 49% 2 yr: 28%	NL
Hunold et al. [8]	To + Cy	54	44.4%	1 yr: 61%	23.1 m = 25.9%
Raciborska et al. [9]	V + Ir + Te	22	68.1%	NL	10.3 m = 22.7%
Casey et al. [10]	Ir + Te	20	63.1%	NL	NL
Van Maldegem et al. [11]	E + Ca/Ci	107	NL	5 yr: 20 - 24.5%	NL